NCT05204069View on ClinicalTrials.gov

Screening for 3-D Visual Disorders in Preschool Children

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions

AmblyopiaStrabismusAnisometropia

Interventions

DRUG

Instillation of cyclopentolate

Instillation of cyclopentolate of 3 drops of cyclopentolate at t0',t5' and t10' with to induce a certain level of cycloplegia and evaluate manifest refraction at t45' using the RetinoMax Device.

Trial Locations (1)

75019

Robert Debre Hospital, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05204069 - Screening for 3-D Visual Disorders in Preschool Children | Biotech Hunter | Biotech Hunter